Stock A084110 HUONS GLOBAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Huons Global Co., Ltd.

Equities

A084110

KR7084110006

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 13/05/2024 BST 		5-day change 1st Jan Change
21,950 KRW +1.62% Intraday chart for Huons Global Co., Ltd. 0.00% -7.19%
03-20 Huons Global Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Huons Global Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 479,396 400,643 348,913 477,988 229,651 289,667
Enterprise Value (EV) 1 458,178 386,210 315,789 350,575 144,102 223,976
P/E ratio 15.8 x 14.3 x 7.8 x 120 x -3.82 x 7.55 x
Yield 1.13% 1.14% 1.3% 1.24% 2.67% 2.22%
Capitalization / Revenue 1.27 x 0.89 x 0.67 x 0.82 x 0.35 x 0.38 x
EV / Revenue 1.21 x 0.86 x 0.6 x 0.6 x 0.22 x 0.3 x
EV / EBITDA 5.46 x 4.13 x 2.75 x 3.36 x 1.2 x 1.47 x
EV / FCF -41.8 x 25.5 x 29.5 x -9.06 x -25.9 x -4.45 x
FCF Yield -2.39% 3.92% 3.39% -11% -3.87% -22.5%
Price to Book 1.26 x 1.06 x 0.84 x 0.89 x 0.49 x 0.58 x
Nbr of stocks (in thousands) 12,570 12,566 12,525 12,415 12,248 12,248
Reference price 2 38,138 31,882 27,857 38,500 18,750 23,650
Announcement Date 07/03/19 11/03/20 11/03/21 23/03/22 23/03/23 20/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 378,687 449,423 523,048 579,937 664,365 758,380
EBITDA 1 83,843 93,566 114,835 104,491 120,376 151,929
EBIT 1 67,996 72,905 89,249 75,170 86,735 115,949
Operating Margin 17.96% 16.22% 17.06% 12.96% 13.06% 15.29%
Earnings before Tax (EBT) 1 77,297 71,150 111,793 62,502 655.3 119,633
Net income 1 28,906 26,657 42,696 3,995 -60,254 38,384
Net margin 7.63% 5.93% 8.16% 0.69% -9.07% 5.06%
EPS 2 2,415 2,227 3,573 321.7 -4,903 3,134
Free Cash Flow 1 -10,971 15,128 10,714 -38,714 -5,572 -50,300
FCF margin -2.9% 3.37% 2.05% -6.68% -0.84% -6.63%
FCF Conversion (EBITDA) - 16.17% 9.33% - - -
FCF Conversion (Net income) - 56.75% 25.09% - - -
Dividend per Share 2 431.9 362.8 362.8 476.2 500.0 525.0
Announcement Date 07/03/19 11/03/20 11/03/21 23/03/22 23/03/23 20/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period:
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 21,217 14,433 33,124 127,413 85,549 65,691
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -10,971 15,128 10,714 -38,714 -5,572 -50,300
ROE (net income / shareholders' equity) 11.9% 10.2% 14.7% 4.24% -4.01% 10.8%
ROA (Net income/ Total Assets) 6.62% 6.44% 6.6% 4.21% 4.29% 5.66%
Assets 1 436,344 413,920 647,242 94,921 -1,404,329 678,264
Book Value Per Share 2 30,257 30,122 33,069 43,321 37,909 40,972
Cash Flow per Share 2 5,799 5,836 8,752 17,591 23,077 19,731
Capex 1 52,638 35,330 64,126 144,448 75,924 79,774
Capex / Sales 13.9% 7.86% 12.26% 24.91% 11.43% 10.52%
Announcement Date 07/03/19 11/03/20 11/03/21 23/03/22 23/03/23 20/03/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
HUONS GLOBAL CO., LTD. Stock Huons Global Co., Ltd.
-7.19% 199M
MERCK KGAA Stock Merck KGaA
+15.44% 78.37B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+11.98% 9.08B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+54.35% 4.85B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-12.85% 5.06B
YUHAN CORPORATION Stock Yuhan Corporation
+1.60% 3.85B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-20.85% 2.36B
INDIVIOR PLC Stock Indivior PLC
+18.23% 2.37B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-29.25% 2.22B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+24.62% 2.27B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A084110 Stock
  4. Financials Huons Global Co., Ltd.
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return**#ffffff**/services/solutions/**#004eff**#000000**Replicate our performance**1**